Home
About
FAQ
History (13)
XBP-1 promotes cell survival by activating the unfolded protein response (UPR) in antiestrogen resistance in breast cancer
Clinical impact of analgesic-sedative agents and peri-operative clinical status on white matter brain injury in preterm infants following surgical NEC.
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
Ortega VE, Peters SP. Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Curr Opin Pharmacol. 2010 Jun; 10(3):246-53.
View in:
PubMed
subject areas
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Asthma
Clinical Trials as Topic
Drug Therapy, Combination
Glucocorticoids
Humans